These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1127)

  • 1. Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor.
    Lohrmann HP; Dietrich M; Goldmann SF; Kristensen T; Fliedner TM; Abt C; Pflieger H; Flad HD; Kubanek B; Heimpel H
    Blut; 1975 Dec; 31(6):347-54. PubMed ID: 1127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of the relative response index with marrow graft rejection in patients with aplastic anemia.
    Mickelson EM; Fefer A; Storb R; Thomas ED
    Transplantation; 1976 Sep; 22(3):294-302. PubMed ID: 135386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.
    Storb R; Thomas ED; Weiden PL; Buckner CD; Clift RA; Fefer A; Fernando LP; Giblett ER; Goodell BW; Johnson FL; Lerner KG; Neiman PE; Sanders JE
    Blood; 1976 Dec; 48(6):817-41. PubMed ID: 11859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with incompatible maternal donors for bone marrow transplantation.
    Feig SA; Falk PM; Neerhout RC; Sparkes R; Gale RP; Opelz G; Cline MJ; Fahey J; Smith G; Sarna G; Territo M; Young L; Langdon EA; Fawzi F
    Blut; 1977 Jan; 34(1):1-10. PubMed ID: 12847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemia.
    Tsoi MS; Warren RP; Storb R; Witherspoon RP; Mickelson E; Giblett ER; Schanfield MS; Weiden P; Thomas ED
    Exp Hematol; 1983 Jan; 11(1):73-81. PubMed ID: 6219886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful bone marrow transplantation against mixed lymphocyte culture barrier.
    Feig SA; Opelz G; Winter HS; Falk PM; Neerhout RC; Sparkes R; Gale RP
    Blood; 1976 Sep; 48(3):385-91. PubMed ID: 8180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
    Hamblin M; Marsh JC; Lawler M; McCann SR; Wickham N; Dunlop L; Ball S; Davies EG; Hale G; Waldmann H; Gordon-Smith EC
    Bone Marrow Transplant; 1996 May; 17(5):819-24. PubMed ID: 8733704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone marrow transplantation in severe aplastic anemia and acute leukemia].
    Speck B; Sartorius J; Cornu P; Nissen C; Weber W; Gratwohl A
    Onkologie; 1979 Apr; 2(2):79-82. PubMed ID: 42865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
    Castro-Malaspina H; Childs B; Laver J; Shank B; Brochstein J; Gillio A; Flomenberg N; Young J; Boulad F; Black P
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):847-54. PubMed ID: 8040033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrelated donor marrow transplantation for severe aplastic anaemia.
    Howard MR
    Transfus Sci; 1991; 12(3):123-34. PubMed ID: 10149542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia.
    Storb R; Prentice RL; Thomas ED; Appelbaum FR; Deeg HJ; Doney K; Fefer A; Goodell BW; Mickelson E; Stewart P
    Br J Haematol; 1983 Dec; 55(4):573-85. PubMed ID: 6231046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization against non-HLA antigens following bone marrow graft rejection.
    Opelz G; Territo MC; Gale RP; Sparkes R
    Tissue Antigens; 1977 Apr; 9(4):209-19. PubMed ID: 17932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of genetically determined histocompatibility antigen differences between HL-A identical and MLC nonreactive siblings.
    Parkman R; Rosen FS; Rappeport J; Camitta B; Levey RL; Nathan DG
    Transplantation; 1976 Feb; 21(2):110-6. PubMed ID: 129895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.
    Anderlini P; Wu J; Gersten I; Ewell M; Tolar J; Antin JH; Adams R; Arai S; Eames G; Horwitz ME; McCarty J; Nakamura R; Pulsipher MA; Rowley S; Leifer E; Carter SL; DiFronzo NL; Horowitz MM; Confer D; Deeg HJ; Eapen M
    Lancet Haematol; 2015 Sep; 2(9):e367-75. PubMed ID: 26685770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors.
    Gordon-Smith EC; Fairhead SM; Chipping PM; Hows J; James DC; Dodi A; Batchelor JR
    Br Med J (Clin Res Ed); 1982 Sep; 285(6345):835-7. PubMed ID: 6214294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.
    Tzeng CH; Chen PM; Fan S; Liu JH; Chiou TJ; Hsieh RK
    Bone Marrow Transplant; 1996 Aug; 18(2):273-7. PubMed ID: 8864434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.